Sorrento Therapeutics
SRNEQ
#10210
Rank
NZ$27.24 M
Marketcap
NZ$0.04942
Share price
3.45%
Change (1 day)
-92.04%
Change (1 year)

Sorrento Therapeutics (SRNEQ) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : NZ$1.07 Billion

According to Sorrento Therapeutics 's latest financial reports the company's total liabilities are NZ$1.07 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sorrento Therapeutics - Total liabilities on balance sheet (from 2004 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$0.77 B-13.73%
2021-12-31NZ$0.90 B64.89%
2020-12-31NZ$0.54 B-29.74%
2019-12-31NZ$0.77 B25.49%
2018-12-31NZ$0.62 B96.03%
2017-12-31NZ$0.31 B-30.35%
2016-12-31NZ$0.45 B53.68%
2015-12-31NZ$0.29 B606.45%
2014-12-31NZ$41.89 M33.59%
2013-12-31NZ$31.36 M4316.6%
2012-12-31NZ$0.71 M54.23%
2011-12-31NZ$0.46 M-41.19%
2010-12-31NZ$0.78 M61.04%
2009-12-31NZ$0.48 M140.19%
2008-12-31NZ$0.2 M4619.21%
2007-12-31NZ$0 M-99.36%
2006-12-31NZ$0.66 M1308.37%
2005-12-31NZ$0.04 M-90.04%
2004-12-31NZ$0.47 M-8.69%
2003-12-31NZ$0.52 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Karyopharm Therapeutics
KPTI
NZ$0.60 B-44.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.09 B 1.25%๐Ÿ‡บ๐Ÿ‡ธ USA